Related by context. All words. (Click for frequent words.) 79 prostate cancers 77 lung cancers 76 colorectal cancers 76 ovarian cancers 76 cancers 75 breast tumors 74 colon cancers 74 colorectal cancer 72 ovarian cancer 72 breast cancer 72 invasive breast cancer 72 tumors 71 endometrial cancers 71 pancreatic cancers 71 bladder cancers 71 bowel cancers 68 lung tumors 67 melanomas 67 cervical cancers 67 endometrial cancer 67 ovarian tumors 66 colon cancer 66 cervical cancer 66 prostate cancer 65 malignancy 65 prostate tumors 65 melanoma 65 invasive cervical cancer 65 BRCA mutations 65 HER2 positive breast cancer 64 adenocarcinoma 64 colorectal cancer CRC 64 malignancies 64 breast cancer recurrence 64 thyroid cancers 64 adenocarcinomas 64 HER2 positive 64 lung cancer 64 adenomas 63 lobular cancer 63 hereditary breast cancer 63 estrogen receptor negative 63 metastases 63 Ovarian cancer 63 DCIS 63 skin cancers 63 squamous cell carcinomas 62 rectal cancer 62 bowel cancer 62 nonmelanoma skin cancers 62 carcinoma 62 lobular carcinoma 61 basal cell carcinomas 61 squamous cell carcinoma 61 gastric cancer 61 uterine cancers 61 carcinomas 61 NSCLC 61 estrogen receptor positive 61 metastatic prostate cancer 61 gynecologic cancers 61 adenoma 61 colorectal tumors 61 atypical hyperplasia 61 malignant tumors 61 pre cancerous lesions 61 breast carcinomas 61 metastatic disease 61 ductal cancer 61 lobular breast cancer 61 HPV 61 ductal carcinoma 61 HER2 60 colon tumors 60 gastric cancers 60 oropharyngeal cancer 60 cancer 60 pre cancerous polyps 60 metastasis 60 metastatic cancer 60 hormone receptor positive 60 GISTs 60 malignant melanoma 60 GBM tumors 60 lymphomas 59 Breast cancer 59 pancreatic tumors 59 cervical lesions 59 BRCA1 mutations 59 metastatic breast cancer 59 rectal cancers 59 neuroendocrine tumors 59 medullary thyroid cancer 59 precancerous lesions 59 gliomas 59 HNSCC 59 testicular cancers 59 curable cancers 59 breast carcinoma 59 advanced adenomas 59 BRCA1 59 PCa 59 adenomatous polyps 59 Cancers 58 Colorectal cancer 58 HPV infection 58 benign growths 58 lung adenocarcinoma 58 epithelial ovarian cancer 58 EGFR 58 prostate cancer CaP 58 HPV infections 58 atypia 58 Lung cancer 58 EGFR mutation 58 Prostate cancer 58 invasive carcinoma 58 HER2 positive tumors 58 pancreatic adenocarcinoma 58 gastrointestinal cancers 58 metastatic 58 Cervical cancer 58 gynecological cancers 58 BRCA mutation carriers 58 bladder cancer 58 polyps 58 breast lesions 58 malignant melanomas 58 distant metastases 57 squamous cell 57 BRCA2 57 situ DCIS 57 oesophageal cancer 57 BRCA mutation 57 Testicular cancer 57 abnormal mammograms 57 micrometastases 57 BRCA1 mutation 57 invasive ductal carcinoma 57 colorectal polyps 57 pre cancerous cells 57 seminoma 57 liver cancer 57 glioblastomas 57 ductal breast cancer 57 tumor 57 basal cell carcinoma 57 Tumours 57 BRCA1 gene 57 HPV# 57 tamoxifen 57 medulloblastoma 57 CaP 57 brain tumors 57 glioblastoma 57 mesotheliomas 57 pancreatic cancer 57 Her2 56 chlamydial infection 56 esophageal cancers 56 serous ovarian cancer 56 colorectal 56 progesterone receptor negative 56 BRCA2 mutations 56 gynecologic cancer 56 Bladder cancer 56 squamous cell cancers 56 operable breast cancer 56 nonsmall cell lung cancer 56 precancerous cervical lesions 56 nonmelanoma skin cancer 56 renal cell carcinoma 56 benign polyps 56 BRCA 56 renal cell carcinomas 56 pancreatic tumor 56 chromosomal abnormalities 56 colon polyps 56 grade gliomas 56 tumor recurrence 56 estrogen receptor 56 gene mutations 56 lymph node metastases 56 squamous cell cancer 56 prostate tumor 56 HPV types 56 tumor cells 56 brain metastases 56 pre menopausal 56 benign breast 56 Barrett esophagus 56 medulloblastomas 56 axillary lymph nodes 56 precancer 56 EGFR mutations 56 abnormal mammogram 55 liver metastases 55 endometrial hyperplasia 55 pleural mesothelioma 55 fibroadenomas 55 polycystic ovary syndrome PCOS 55 Basal cell carcinoma 55 precursor lesions 55 leukaemias 55 HER2 negative 55 HER2 + 55 metastatic tumors 55 GIST tumors 55 genes BRCA1 55 pancreatic lung 55 precancerous polyps 55 neuroblastomas 55 anal cancers 55 advanced adenoma 55 pre cancerous growths 55 HER2 positive cancers 55 invasive ductal 55 melanoma tumors 55 cancerous cells 55 ALCL 55 peritoneal cancer 55 osteosarcomas 55 precancerous 55 distant metastasis 55 atypical ductal hyperplasia 55 ischemic strokes 55 colorectal adenomas 55 oophorectomy 55 postmenopausal breast cancer 55 estrogen receptor ER 55 premenopausal breast cancer 55 precancers 55 neoplasms 55 premenopausal 55 colorectal polyp 55 uveal melanoma 55 BRCA2 mutation 55 breast ovarian 55 Stomach cancer 54 Tumors 54 mammary tumors 54 breast tissue 54 precancerous cells 54 breast endometrial 54 bone metastasis 54 carcinoid cancer 54 ductal carcinomas 54 neoplasias 54 precancerous growths 54 cell lung cancer 54 preeclampsia 54 squamous cell lung cancer 54 situ LCIS 54 malignant lesions 54 aneuploidy 54 neoplasia 54 breast biopsies 54 lung nodules 54 MGUS 54 epithelial tumors 54 HER2 overexpression 54 BRCA deficient 54 cancerous tumors 54 breast cancer recurrences 54 dense breasts 54 preterm births 54 prostate specific 54 sentinel nodes 54 NAFLD 54 Uterine fibroids 54 malignant growths 54 Gastric cancer 54 contralateral breast cancer 54 LQTS 54 Bowel cancer 54 cutaneous melanoma 54 gynecologic malignancy 54 colorectal neoplasia 54 invasive ductal carcinomas 54 metastatic lesions 54 EUS FNA 54 esophageal adenocarcinoma 54 carcinoid tumors 54 thyroid nodules 54 mammographic density 54 BRAF gene 54 mutations 54 familial ALS 54 gene mutation 54 ccRCC 53 bladder tumors 53 metastatic melanomas 53 endometrial carcinoma 53 Wilms tumor 53 mutated BRCA1 53 systemic scleroderma 53 testicular tumors 53 gene variants 53 pre cancerous 53 inherited mutations 53 cell carcinoma 53 human papillomavirus HPV 53 colorectal carcinoma 53 oesophageal adenocarcinoma 53 BRCA genes 53 screening mammography 53 CIN3 + 53 Endometrial cancer 53 BRCA1 mutation carriers 53 Polyps 53 lymph node involvement 53 postmenopausal women 53 genetic mutations 53 invasive cervical cancers 53 malignant pleural mesothelioma 53 prostate cancer PCa 53 cervical carcinoma 53 carcinoid 53 basal cell carcinoma BCC 53 node metastases 53 cancerous breast 53 testicular cancer 53 BRAF mutation 53 cardiovascular disease 53 breast cancer metastasis 53 basal cell 53 incidentalomas 53 overexpress HER2 53 seminomas 53 mammary cancers 53 PSA screening 53 benign tumors 53 Colorectal cancers 53 metastatic colorectal cancer 53 molecular abnormalities 53 differentiated thyroid 53 contralateral breast 53 invasive lobular carcinoma 53 prostate adenocarcinoma 53 hamartomas 53 hormonal therapy 53 Inflammatory breast cancer 53 uterine cancer 53 hepatocellular carcinoma HCC 53 hepatocellular cancer 53 lymph nodes 53 periodontitis 53 cancerous lesions 53 epithelial cancers 53 mutated gene 53 Adenocarcinoma 53 Esophageal cancer 53 premalignant lesions 53 ependymoma 53 factor receptor 53 fibroids 53 post menopausal 53 intestinal polyps 53 adjuvant therapy 53 p# mutations 53 BRCA gene mutation 53 GIST 53 premalignant 53 abnormal cervical 53 oncogenic HPV types 53 cervical precancers 53 estrogen receptors 53 Pancreatic cancer 53 ovarian lung 52 vulvar cancers 52 heart disease 52 ovarian 52 benign proliferative breast 52 epithelial ovarian 52 advanced neoplasia 52 follicular lymphoma 52 basal cell cancers 52 precancerous polyp 52 anaplastic 52 tumor suppressor genes 52 ASCUS 52 lymphoma 52 Carcinoma 52 ovarian carcinoma 52 preterm delivery 52 neuroblastoma 52 estrogen progestin therapy 52 genital herpes infections 52 aromatase inhibitors 52 soft tissue sarcomas 52 prostate biopsies 52 axillary dissection 52 pathogenic mutations 52 Renal cell carcinoma 52 subclinical hyperthyroidism 52 Glioblastoma 52 Papillary 52 estrogen receptor progesterone receptor 52 squamous cell carcinoma SCC 52 hepatocellular carcinoma 52 Cristofanilli 52 FGFR2 52 PARP inhibitors 52 lobular carcinomas 52 pre eclampsia 52 recurrent ovarian cancer 52 malignant cells 52 abnormal Pap 52 basal cell nevus syndrome 52 poorer prognosis 52 SLNB 52 genetic variants 52 pCR 52 colorectal neoplasms 52 uterine ovarian 52 PSA velocity 52 genetic abnormalities 52 hormone therapy estrogen 52 gestational diabetes 52 denser breasts 52 testicular germ cell 52 commonly mutated genes 52 paragangliomas 52 ErbB2 positive 52 vulvar cancer 52 endostatin 52 familial pancreatic cancer 52 basal cell cancer 52 papillary 52 abnormal growths 52 prostate breast 52 chronic prostatitis 52 Squamous cell carcinoma 52 breast cancer gene mutation 52 atherosclerotic lesions 52 localized prostate cancer 52 H. pylori 52 CIN2 52 Metastases 52 HGPIN 52 benign lesions 52 colo rectal cancer 52 CIN3 52 metastatic lung cancer 52 leukemias 52 cancerous polyps 52 HER2/neu 52 preventive mastectomies 52 cancerous growths 52 acute myelogenous leukemia AML 52 gastric adenocarcinoma 52 gynecological cancer 52 ovulatory infertility 52 adenomatous polyp 52 liver metastasis 52 cell lymphomas 52 EGFR gene 52 Hepatocellular Carcinoma HCC 51 DLBCL 51 colon breast 51 genetic variant 51 hypermethylation 51 endometriosis 51 NF1 51 CIN2 + 51 Pap smear 51 hormone receptor negative 51 Cholangiocarcinoma 51 Oesophageal cancer 51 glandular tissue 51 cisplatin resistant 51 mutation 51 esophageal tumors 51 untreated celiac disease 51 metastatic cancers 51 BRCA2 mutation carriers 51 IGF 1R 51 leiomyomas 51 thyroid cancer 51 malignant lymphoma 51 urothelial carcinoma 51 sentinel node biopsy 51 NKX2 51 Acoustic neuromas 51 Squamous cell 51 HNPCC 51 narcolepsy cataplexy 51 nodular melanoma 51 cyclin E 51 malignant neoplasm 51 uterine fibroids 51 de ath 51 mammograms 51 venous blood clots 51 sporadic ALS 51 cervical intraepithelial neoplasia 51 Thyroid nodules 51 BRCA gene mutations 51 aromatase 51 Gliomas 51 ARVD 51 mitochondrial fusion 51 Dr Zorbas 51 endocrine tumors 51 meningiomas 51 metastatic prostate 51 tumor subtypes 51 HCV infections 51 squamous cell skin 51 HER2 protein 51 Pap smear screening 51 MSH2 51 Acute lymphoblastic leukemia 51 aneurysms 51 prophylactic mastectomy 51 sarcomas 51 microdeletions 51 Recurrences 51 breast lumps 51 tumor suppressor gene 51 malignant gliomas 51 pheochromocytomas 51 mtDNA mutations 51 atrial fibrillation 51 leiomyosarcoma 51 ADPKD 51 malignant polyps 51 polycythemia vera 51 PCNSL 51 neoplasm 51 mammographic screening 51 biopsies 51 sentinel node 51 Pancreatic neuroendocrine tumors 51 penile cancers 51 Melanomas 51 Metastatic 51 BRCA2 gene mutation 51 colorectal bowel 51 KRAS mutations 51 PSADT 51 acid secretion 51 HLA B# 51 estrogen 51 EGFRvIII 51 mammography 51 renal carcinoma 51 prostate tissue 51 PGDH 51 colorectal adenoma 51 ovarian breast 51 BRCA carriers 51 perimenopausal women 51 salpingo oophorectomy 51 nasopharyngeal carcinoma 51 coronary artery disease 51 CMV infection 51 Colon polyps 51 recurrences 51 NF2 51 breast caner 51 papillary thyroid cancer 51 neuroendocrine carcinoma 51 axillary lymph node dissection 51 cisplatin 51 axillary node dissection 51 surgical biopsies 51 prostrate cancer 51 mammographies 51 colonoscopy screenings 51 histological subtype 51 cyclin D1 51 screening mammogram 51 gene variant 51 prediabetes 51 ApoE4 51 olaparib 51 prostate pancreatic 51 preterm deliveries 51 HER2 receptor 51 Uterine cancer 51 ruptured aneurysms 51 Thyroid cancer 51 recurrent VTE 51 Chlamydia infection 50 APOE e4 gene 50 genetic mutation 50 neuroblastoma tumors 50 bowel polyps 50 Melanoma 50 faulty BRCA genes 50 metastatic colon cancer 50 colorectal gastric 50 unneeded biopsies 50 autoantibodies 50 BRCA2 gene mutations 50 breast prostate 50 lobules 50 angiosarcoma 50 KRAS mutation 50 polyp recurrence 50 coronary disease 50 uterine tumors 50 factor receptor EGFR 50 mammary cells 50 hormonal therapies 50 metastatic colorectal 50 Caesarean deliveries 50 noncancerous tumors 50 ductal 50 BCR ABL 50 mucinous 50 renal tumors 50 GnRH agonists 50 tyrosine kinase inhibitors 50 cardio vascular disease 50 folate deficiency 50 proliferative diabetic retinopathy 50 metastatic melanoma 50 IDH1 mutation 50 specific antigen 50 glioma 50 abnormal Pap smears 50 estrogen therapy 50 sarcosine 50 HER2 positive breast 50 K ras gene 50 colon polyp 50 familial adenomatous polyposis 50 hormone estrogen 50 gene BRCA2 50 polycystic ovarian syndrome PCOS 50 folic acid intake 50 esophageal cancer 50 HCV infection 50 lung adenocarcinomas 50 glioblastoma tumors 50 Adjuvant chemotherapy 50 skeletal metastases 50 DCIS lesions 50 breast cancer genes BRCA1 50 preoperative chemotherapy 50 germline mutations 50 ductal adenocarcinoma 50 mutant protein 50 Pap test 50 disease progression 50 HER-2/neu 50 invasive ductal breast cancer 50 colorectal cancer screening 50 laryngeal cancer 50 androgens 50 hormone therapy 50 EZH2 50 imatinib resistance 50 prophylactic mastectomies 50 pancreatic NET 50 ErbB2 50 COPD 50 artery blockages 50 EGFR protein 50 cervical dysplasia 50 cancerdefine 50 mutated genes 50 adjuvant chemotherapy 50 malignant nodules 50 Fibroids 50 rectal carcinoma 50 hemorrhagic strokes 50 vaginal cancers 50 HER2 gene 50 leukemia ALL 50 ependymomas 50 tumor histology 50 melanoma skin 50 lymph node 50 breast cancer subtypes 50 non Hodgkin lymphomas 50 aromatase inhibitor 50 PTEN mutations 50 ZNF# 50 ovarian colorectal 50 abnormal Pap tests 50 yearly mammograms 50 sentinel lymph node biopsy 50 CMV disease 50 chromosomal aberrations 50 gene amplification 50 osteoporotic fractures 50 aneuploid cells 50 alveolar rhabdomyosarcoma 50 lung carcinomas 50 colorectal carcinomas 50 cervical abnormalities 50 lymph node metastasis 50 NNRTI resistance 50 chemoradiation 50 malignant transformation 50 tumor shrinkage 50 Rectal cancer 50 Basal cell 50 undergone hysterectomy 50 ovulations 50 mutated KRAS gene 50 choriocarcinoma 50 exemestane 50 c MYC 50 ovulatory cycles 50 grade glioma 50 chlamydia infections 50 FSGS 50 gallstone disease 50 cardiovascular disease CVD 50 liver fibrosis 50 genetic variations 50 Ductal carcinoma 50 BRAF mutations 50 prostate 50 pancreatic ovarian 50 medulloblastoma tumors 50 fibrocystic disease 50 cutaneous squamous cell carcinoma 49 urothelial cancer 49 precancerous tumors 49 Malignant Melanoma 49 Tamoxifen 49 Enlarged prostate 49 breast pancreatic 49 ALK mutations 49 HER2 expression 49 SPINK1 49 elevated triglyceride levels 49 IDH2 49 endometrial 49 Breast Cancers 49 oesophageal squamous cell carcinoma 49 Glioblastomas 49 breast conserving 49 screening mammograms 49 cell carcinomas 49 Carcinoid tumors 49 lupus 49 HER2 amplification 49 Abdominal aortic aneurysms 49 antigen PSA 49 Non Hodgkin lymphoma 49 neoadjuvant chemotherapy 49 Adenomas 49 Epithelial ovarian cancer 49 prostate lung 49 premenopausal women 49 grade cervical intraepithelial 49 peritoneal carcinomatosis 49 multiple myeloma 49 disease NAFLD 49 subtype 49 European Randomized Study 49 noncancerous 49 HMGA2 49 dutasteride 49 invasive meningococcal disease 49 Malignant melanoma 49 somatic mutations 49 lymphedema 49 solid tumors 49 H. pylori infection 49 pelvic malignancies 49 TCF#L# 49 thyroglobulin 49 carotid stenosis 49 primary biliary cirrhosis 49 prostate carcinoma 49 frequently benign tumor 49 HER2 ErbB2 49 uPAR 49 lymph node removal 49 TT genotype 49 Hepatocellular carcinoma 49 Human papillomavirus HPV 49 invasive lobular 49 lipid abnormalities 49 unnecessary biopsies 49 B7 H3 49 K ras mutations 49 spontaneous preterm birth 49 Seewaldt 49 osteoporotic fracture 49 prostate specific antigen 49 gastrointestinal stromal tumors 49 CLL 49 elevated CRP 49 MSMB 49 vertebral fractures 49 Hashimoto thyroiditis 49 Anal cancer 49 oesophageal 49 undergoing hysterectomy 49 carcinoid tumor 49 BRAF protein 49 SCCHN 49 anaplastic lymphoma kinase 49 tamoxifen therapy 49 distal colon cancer 49 childhood leukemia 49 imatinib Gleevec 49 PARP inhibition 49 WT1 49 IKZF1 49 Malignant mesothelioma 49 liver scarring 49 KRAS 49 malignant brain 49 retinoblastoma 49 pharyngeal cancer 49 preventive mastectomy 49 carcinogenesis 49 telomere lengths 49 ductal lobular 49 ischemic stroke 49 ApoE4 gene 49 Acute myeloid leukemia 49 CDH1 49 benign nodules 49 GSTT1 49 Pap smears 49 esophageal squamous cell carcinoma 49 mammographically 49 occult metastases 49 myeloid cells 49 tumor progression 49 Oncogenes 49 synovial sarcoma 49 colon rectal cancer 49 oropharyngeal cancers 49 Barrett Esophagus 49 TGFBR1 * 6A 49 acute leukemias 49 genetic variants associated 49 pre cancerous lesion 49 GSTP1 49 APOL1 49 atherosclerosis 49 CT colonography 49 liposarcoma 49 armpit lymph nodes 49 GNAQ 49 Breast Cancer Risk 49 ovarian pancreatic 49 autoantibody 49 pre malignant lesions 49 venous thromboembolism 49 Human papilloma virus 49 calcifications 49 endogenous estrogen 49 MYCN amplification 49 carcinoma HNSCC 49 castration resistant prostate cancer 49 locoregional recurrence 49 hepatocellular carcinomas 49 Digital Mammographic Imaging 49 Squamous cell carcinomas 49 detect precancerous lesions 49 nodal metastases 49 H. pylori eradication 49 hyperemesis gravidarum 49 precancerous cervical 49 PARP inhibitor 49 sarcoma 49 hormone deprivation 49 FGFR1 49 pituitary adenomas 49 malignant mesothelioma 49 medically inoperable 49 superficial bladder cancer 49 cetuximab 49 metastatic renal cell carcinoma 49 aneuploidies 49 recurrent miscarriage 49 basal cell skin 49 Fibroid tumors 49 anastrozole 49 gastrointestinal malignancies 49 mastectomies 49 adjuvant radiation 49 BRCA1 BRCA2 49 Colon Cancer 49 IDH1 49 prostate colon 49 ABCB1 49 Flexi Scope 49 HER2 positivity 49 MALT lymphoma 48 estrogen progesterone 48 cervical screening 48 K ras 48 PKCi 48 Glioblastoma Multiforme GBM 48 abnormal Pap smear 48 pulmonary metastases 48 endometrial tumors 48 chronic lymphocytic leukemia CLL 48 Lung Cancer 48 EBV infection 48 BRCA gene 48 Diverticulosis 48 Epstein Barr virus EBV 48 pilocytic astrocytomas 48 Peutz Jeghers syndrome 48 bacterial overgrowth 48 Glioma 48 androgenic alopecia 48 diffuse gastric 48 neoadjuvant therapy 48 Malignant tumors 48 Cell Lung Cancer 48 PIK3CA 48 Metastatic breast cancer 48 hereditary predisposition 48 cystatin C 48 gastrointestinal GI cancers 48 meningioma 48 colorectal tumor 48 HER2 amplified 48 Colorectal cancer screening 48 Recurrence Score 48 lung colorectal 48 prostate ovarian 48 chromosomal alterations 48 coronary blockages 48 gene variation 48 Brain metastases 48 epigenetic changes 48 B Cell Lymphoma 48 STAT3 48 grade dysplasia 48 relapsed ovarian cancer 48 colonic polyps 48 thyroid tumors 48 oncogene 48 HPV strains 48 MCADD 48 cerebral infarction 48 Peritoneal mesothelioma 48 lumpectomy 48 gastrointestinal stromal tumor 48 micro calcifications 48 cardiovascular mortality 48 subclinical hypothyroidism 48 overexpressed 48 Inflammatory Breast Cancer 48 surgical biopsy 48 symptomatic fibroids 48 vulvar intraepithelial neoplasia 48 CLA supplementation 48 taxane therapy 48 epidermal growth 48 breast colorectal 48 pituitary tumors 48 sCJD 48 menopausal hormone therapy 48 ApoE 48 papillary carcinoma 48 BRCA2 carriers 48 neovascular AMD 48 HIV infection 48 KRAS oncogene 48 lobular 48 lung pancreatic 48 male hormones androgens 48 histologic subtype 48 hip fractures 48 HER2 receptors 48 lung colon 48 Ischemic strokes 48 benign noncancerous 48 metachronous 48 premature menopause 48 abnormal cytology 48 colorectal liver metastases 48 PTEN gene 48 EGFR inhibitors 48 cranial radiation 48 p# mutation 48 axillary nodes 48 SUVmax 48 thromboembolic events 48 oropharyngeal squamous cell carcinoma 48 transitional cell carcinoma 48 cancerous polyp 48 intensive statin therapy 48 postmenopausal hormone 48 Malignant gliomas 48 overexpression 48 gene fusions 48 breast cancer susceptibility genes 48 erlotinib 48 cervical breast 48 lobular involution 48 Burkitt lymphoma